dbGAP Study | dbGAP Variable | dbGAP Variable Description |
A Genome Wide Scan of Lung Cancer and Smoking |
phv00070924 |
Gender: male or female |
A Genome Wide Scan of Lung Cancer and Smoking |
phv00022944 |
Gender: male or female |
A Genome Wide Scan of Lung Cancer and Smoking |
phv00022954 |
Gender: male or female |
A Genome-Wide Association Study of Peripheral Arterial Disease |
phv00076111 |
Gender of participant |
A Multiethnic GWAS of Prostate Cancer |
phv00124441 |
Gender |
A Multiethnic GWAS of Prostate Cancer |
phv00142466 |
Gender |
A Multiethnic GWAS of Prostate Cancer |
phv00142487 |
Gender |
A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic Melanoma |
phv00164876 |
Gender of participant |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173611 |
Gender of participant as defined by genotype |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173612 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173613 |
Gender of participant as identified by survey of patient/patient's parent |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173631 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173632 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173633 |
Gender of participant as identified by survey of patient/patient's parent |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173658 |
Gender of participant as defined by genotype |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173659 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173660 |
Gender of participant as identified by survey of patient/patient's parent |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173684 |
Gender of participant as defined by genotype |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173685 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173686 |
Gender of participant as identified by survey of patient/patient's parent |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173712 |
Gender of participant as identified by genotype |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173713 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173714 |
Gender of participant as identified by survey of patient/patient's parent |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173740 |
Gender of participant as identified by medical records |
A Study of the Genetic Causes of Complex Pediatric Disorders |
phv00173741 |
Gender of participant as identified by survey of patient/patient's parent |
Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain |
phv00121765 |
Gender of subject |
Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes |
phv00076146 |
Gender of participant |
ADGC Genome Wide Association Study |
phv00171927 |
Gender of participant |
African American Breast Cancer GWAS |
phv00226032 |
Gender of participant |
Alcohol Dependence GWAS in European- and African Americans |
phv00164977 |
Gender of participant |
Alzheimer's Disease Sequencing Project (ADSP) |
phv00192277 |
Sex |
Alzheimer's Disease Sequencing Project (ADSP) |
phv00192282 |
Subject's Sex |
Alzheimer's Disease Sequencing Project (ADSP) |
phv00195357 |
Sex |
Alzheimer's Disease Sequencing Project (ADSP) |
phv00218087 |
Sex |
AMD-MMAP Cohort Study: A Joint Genome Wide Association Study |
phv00073523 |
Gender of participant |
Antigen Discovery in Melanoma |
phv00253333 |
Sex of subject |
ARDSnet and the iSPAAR Consortium: Genetic Studies |
phv00196258 |
Sex |
ARRA Autism Sequencing Collaboration |
phv00167339 |
Gender of participant |
Asian Indian Diabetic Heart Study (AIDHS) |
phv00190530 |
Gender of participant |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00204449 |
A. Hospital Information. GENDER Q9 [Cohort Stroke Abstraction Form, STR] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00204634 |
Sex (from FTRA22) [Cohort, Exam 2] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00204711 |
Sex (uncorrected from FTRA22) [Cohort, Exam 1] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00204963 |
Sex (From FTRA22) [Cohort, Exam 4] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00207078 |
[Reproductive history]. Sex of participant. Q10 [Health/Medical History, exam 2] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00208795 |
Sex (M, F) [Pulmonary Function Test, exam 1] |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00091341 |
GENDER Q9 |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00091486 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00092676 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00092793 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00092928 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00092976 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00094324 |
GENDER OF PARTICIPANT Q10 |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00095960 |
SEX (from FTRA22) |
Atherosclerosis Risk in Communities (ARIC) Cohort |
phv00097872 |
SEX (from FTRA22) |
Autism Genome Project (AGP) Consortium - GWAS - Stage I and II |
phv00161301 |
Gender of individual |
Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC) |
phv00167765 |
Gender of participant |
Autosomal recessive PGM3 mutations cause a new Congenital Disorder of Glycosylation |
phv00219152 |
Gender of participant |
Autosomal recessive TPP2 mutations cause a new human immunodeficiency |
phv00221148 |
Sex |
Autosomal recessive TPP2 mutations cause a new human immunodeficiency |
phv00221156 |
Gender of participant |
B and T Cell Determinants of Influenza Vaccine Responses in the Elderly |
phv00196119 |
Gender of participant |
Baylor Hopkins Center for Mendelian Genomics (BH CMG) |
phv00200346 |
Subject's gender |
Baylor Hopkins Center for Mendelian Genomics (BH CMG) |
phv00200351 |
Subject's gender |
Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans |
phv00173359 |
Sex of participant |
Biology and Molecular Analysis of Human Hematopoiesis Genetics |
phv00168002 |
Gender of participant |
Bladder Cancer Clinical Cohorts |
phv00202613 |
Gender of participant |
BrainCloud: Data from Human Postmortem Brain Across the Lifespan |
phv00163196 |
Gender of subject |
Breakpoint Detection Using Long Insert Whole Genome Sequencing |
phv00193968 |
Gender of participant |
Breast Cancer Study |
phv00220928 |
Gender of participant [Female] |
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217489 |
Gender of participant |
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217501 |
Gender of participant |
Building on GWAS for NHLBI-Diseases : the U.S. CHARGE Consortium (CHARGE-S): ARIC |
phv00217516 |
Gender of participant |
Bulgarian Schizophrenia Trio Sequencing Study |
phv00197315 |
Gender of participant |
BWH MS Genetic Collection |
phv00173776 |
Gender of the participant |
CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer Patients |
phv00159013 |
Gender. This variable indicates the self reported gender of the patient at the time of registration. |
Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS Bladder) |
phv00159001 |
Gender of participant |
Cardiovascular Health Study (CHS) Cohort |
phv00098797 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00100302 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00100810 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00101950 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00105644 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00106545 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00108393 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00109144 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00109854 |
GENDER |
Cardiovascular Health Study (CHS) Cohort |
phv00197398 |
Gender from a-variables table |
Cardiovascular Health Study (CHS) Cohort |
phv00197400 |
Gender |
CCDG: Dental Caries and CL/P in Guatemala |
phv00164848 |
Gender of participant. |
CCHMC - eMERGE Data |
phv00171343 |
Gender of participant |
CD4+ cell transcriptional profiling by RNA sequencing |
phv00193953 |
Gender of participant |
Cebu Longitudinal Health and Nutrition Survey (CLHNS) |
phv00173303 |
Gender of participant |
CGEMS Breast Cancer GWAS |
phv00066640 |
Gender of participant |
CGEMS Prostate Cancer GWAS - Stage 1 - PLCO |
phv00082617 |
Gender of participant |
Characterization of a Metastatic Cervical Cancer Using NGS |
phv00195732 |
Gender of participant |
Characterization of Human Transcriptome by Computational and HTS Approaches |
phv00224900 |
Gender of participant |
Characterization of Pancreatic Adenocarcinoma Patients Using NGS |
phv00179509 |
Gender of participant |
Characterization of X Chromosome Inactivation by high-throughput sequencing |
phv00219126 |
Gender of participant |
Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study |
phv00195755 |
Gender of participant |
Cholesterol and Pharmacogenetics (CAP) Study |
phv00167790 |
Gender [Male or Female] |
CHOP Control CNV Study |
phv00076212 |
Gender of participant |
Chromothripsis in Patient WHIM-09 |
phv00222541 |
Gender of participant |
CIDR Whole Exome Sequencing in Joubert Syndrome |
phv00161522 |
Gender of participant |
CIDR: Collaborative Study on the Genetics of Alcoholism (COGA) |
phv00044647 |
Participant's gender |
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) |
phv00045171 |
Gender |
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) |
phv00045239 |
Gender: male, female (see phs000004: NINDS Repository Neurologically Normal Control Collection) |
CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD) |
phv00051863 |
Gender: male, female |
CIDR: NGRC Parkinson's Disease Study |
phv00075993 |
Self reported male or female. |
Ciliopathies Exome Sequencing Initiative |
phv00165082 |
Gender of subject |
CIP: Differential Response to Hydroxyurea and Incidence of Stroke in Sickle Cell Disease |
phv00196901 |
Gender of participant |
CIP: Obesity-Diabetes Familial Risk |
phv00191155 |
Gender of participant |
Clonal Evolution of Pre-Leukemic HSC Precedes Human AML |
phv00173910 |
Gender of participant |
Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan) |
phv00195374 |
Gender of participant [FEMALE, MALE] |
Collaborative Association Study of Psoriasis |
phv00020011 |
Sex for cases |
Colon Cancer Clinical Cohorts |
phv00224966 |
Gender of participant |
Consanguinity and Rare Mutations Outside of MCCC Genes Underlie Non-Specific Phenotypes of MCC Deficiency |
phv00202353 |
Gender of participant |
Copy Number Variation in Congenital Kidney Malformations |
phv00174498 |
Gender of participant |
CPTAC Proteogenomic Confirmatory Study |
phv00225344 |
Participant gender using the defined categories. [Male; Female; Unknown; Unspecified] |
CPTAC Proteogenomic Confirmatory Study |
phv00225292 |
Participant gender using the defined categories. [Male; Female; Unknown; Unspecified] |
CSER-MedSeq |
phv00252786 |
Gender of subject |
CTLA4 haploinsufficiency and immune dysregulation |
phv00217692 |
Gender |
CTLA4 haploinsufficiency and immune dysregulation |
phv00217701 |
Subject's gender |
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study) |
phv00090655 |
Gender of subject |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00024957 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00025695 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00026039 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00027102 |
Subject's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00027796 |
Patient's gender (coded m or f) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00028718 |
Patient's gender (form 001) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00028966 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00029309 |
Patient's gender (from form 001) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030102 |
Patient's gender (0=male,1=female) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030340 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030687 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030750 |
Patient's gender (form 001) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00030936 |
Patient's gender (from form 001) |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00031783 |
Indicator: male gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00034144 |
Patient's gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00034546 |
Gender |
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes |
phv00051664 |
A4. Identifying information. Gender |
DCEG Lung Cancer Study |
phv00159402 |
Gender of participant [FEMALE, MALE] |
DFCI Brown Lab CLL Sequencing Study |
phv00253297 |
Gender of participant |
DFCI Colorectal Cancer Cohorts |
phv00201985 |
Gender of participant |
Diabetes Prevention Program Genetics (DPPG) |
phv00201854 |
Gender of participant |
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease |
phv00090824 |
Gender |
Discovery of Non-ETS Gene Fusions using RNA Sequencing |
phv00142652 |
Gender of participant |
DNA Methylation Analysis of Prostate Cancer |
phv00181136 |
Gender of subject |
Dobyns DBD |
phv00167279 |
Gender of participant |
Drug Resistant Hypertension in African Americans' Exome |
phv00164734 |
Gender of participant |
Effect of Crohn's Disease Risk Alleles on Enteric Microbiota |
phv00090595 |
Gender of participant |
eMERGE Genome-Wide Association Studies of Obesity |
phv00163596 |
Gender of subject. |
eMERGE Genome-Wide Association Studies of Obesity (Metabochip) |
phv00163767 |
Gender of subject. |
eMERGE Network Combined Dataset |
phv00182445 |
Gender of participant |
eMERGE Network Study of Resistant Hypertension |
phv00163159 |
Gender of participant. |
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes |
phv00195566 |
Gender |
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies |
phv00195518 |
Gender |
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies |
phv00195521 |
Self-declared gender of participant |
Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in Epileptic Encephalopathies |
phv00201601 |
Self-declared gender of participant |
Epigenetic and Genetic Profiling in Lymphoma |
phv00226818 |
Gender of participant |
Epigenetic Marks as Peripheral Biomarkers of Autism |
phv00191073 |
Gender of participant |
Epigenetic Marks as Peripheral Biomarkers of Autism |
phv00191076 |
Subject's gender |
Epigenetic Profiling of Human Colorectal Cancer |
phv00161708 |
Gender of participant |
Exome Chip Study of NIMH Controls |
phv00192229 |
Gender of participant |
Exome Sequencing in Schizophrenia Families |
phv00201670 |
Gender of participant |
Exome sequencing of a family with thrombocytopenia and leukemia |
phv00224938 |
Gender of participant |
Exome Sequencing of arPEO |
phv00162961 |
Gender of Participant |
Exome Sequencing of Esophageal Adenocarcinoma |
phv00190857 |
Participant gender as Male or Female |
Exome Sequencing of Pleuropulmonary Blastoma |
phv00173412 |
Participant's gender as Male or Female |
Familial Exome Sequencing in Rare Pediatric Phenotypes |
phv00179539 |
Gender of participant |
Family Genomics of Congenital Heart Defects |
phv00202713 |
Subject's gender |
Foregut Microbiome in Development of Esophageal Adenocarcinoma |
phv00090620 |
Gender of subject |
Framingham Cohort |
phv00164565 |
Values: Male; Female |
Framingham Cohort |
phv00177929 |
Participant gender |
Framingham Cohort |
phv00021228 |
SEX OF PARTICIPANT |
Framingham Cohort |
phv00024071 |
Gender |
Framingham SHARe Social Network |
phv00073864 |
Gender |
FusionSeq: Finding Fusions with Paired-End RNA-Seq |
phv00156548 |
Gender of participant |
GAW16 Framingham and Simulated Data |
phv00063695 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063727 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063759 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063791 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063823 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063855 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063887 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063919 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063951 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063983 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064015 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064047 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064079 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064111 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064143 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064175 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064207 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064239 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064271 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064303 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064335 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064367 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064399 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064431 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064463 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064495 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064527 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00064559 |
GENDER:1=MALE,2=FEMALE |
GAW16 Framingham and Simulated Data |
phv00064567 |
Gender |
GAW16 Framingham and Simulated Data |
phv00073845 |
Gender |
GAW16 Framingham and Simulated Data |
phv00051702 |
GENDER:1=MALE,2=FEMALE |
GAW16 Framingham and Simulated Data |
phv00051770 |
GENDER:1=MALE,2=FEMALE |
GAW16 Framingham and Simulated Data |
phv00051839 |
GENDER:1=MALE,2=FEMALE |
GAW16 Framingham and Simulated Data |
phv00058159 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058191 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058223 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058255 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058287 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058319 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058351 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058383 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058415 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058447 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058479 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058511 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058543 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058575 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058607 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058639 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058671 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058703 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058735 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058767 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058799 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058831 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058863 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058895 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058927 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058959 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00058991 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059023 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059055 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059087 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059119 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059151 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059183 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059215 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059247 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059279 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059311 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059343 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059375 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059407 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059439 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059471 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059503 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059535 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059567 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059599 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059631 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059663 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059695 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059727 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059759 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059791 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059823 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059855 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059887 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059919 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059951 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00059983 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060015 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060047 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060079 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060111 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060143 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060175 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060207 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060239 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060271 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060303 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060335 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060367 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060399 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060431 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060463 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060495 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060527 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060559 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060591 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060623 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060655 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060687 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060719 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060751 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060783 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060815 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060847 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060879 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060911 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060943 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00060975 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061007 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061039 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061071 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061103 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061135 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061167 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061199 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061231 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061263 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061295 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061327 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061359 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061391 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061423 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061455 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061487 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061519 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061551 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061583 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061615 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061647 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061679 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061711 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061743 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061775 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061807 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061839 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061871 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061903 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061935 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061967 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00061999 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062031 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062063 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062095 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062127 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062159 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062191 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062223 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062255 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062287 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062319 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062351 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062383 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062415 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062447 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062479 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062511 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062543 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062575 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062607 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062639 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062671 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062703 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062735 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062767 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062799 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062831 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062863 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062895 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062927 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062959 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00062991 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063023 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063055 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063087 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063119 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063151 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063183 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063215 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063247 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063279 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063311 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063343 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063375 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063407 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063439 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063471 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063503 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063535 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063567 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063599 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063631 |
Gender 1: Male, 2: Female |
GAW16 Framingham and Simulated Data |
phv00063663 |
Gender 1: Male, 2: Female |
GDNF and Anxiety |
phv00217716 |
Gender of participant |
GEI Studies - Psoriasis |
phv00202295 |
Gender of participant |
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP) |
phv00163633 |
Gender of subject. |
Geisinger eMERGE - MyCode Project |
phv00163391 |
Gender of subject. |
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations) |
phv00081063 |
Reported gender of participant |
Gene Mutation and Rescue in Congenital Diaphragmatic Hernia |
phv00167961 |
Gender of participant |
Genentech Lung Cancer Sequencing |
phv00112391 |
Gender of participant |
Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma Patients |
phv00163921 |
Gender of participant |
Genes and Blood Clotting Study (GABC) |
phv00124352 |
Participant gender |
Genetic Analysis of Hirschsprung Disease |
phv00168116 |
Gender of participant |
Genetic Associations in Idiopathic Talipes Equinovarus (GAIT) |
phv00141836 |
Gender of participant |
Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections |
phv00200422 |
Gender of participant |
Genetic Basis of XMEN Disease |
phv00160299 |
Gender of participant |
Genetic Defects in Familial Renal Disorders |
phv00167981 |
Gender of participant |
Genetic Epidemiology Network of Salt Sensitivity (GenSalt) |
phv00217799 |
Sex |
Genetic Epidemiology Network of Salt Sensitivity (GenSalt) |
phv00217805 |
Sex |
Genetic Epidemiology of COPD (COPDGene) |
phv00159571 |
Gender |
Genetic Heterogeneity of Diffuse Large B Cell Lymphoma |
phv00181331 |
Gender |
Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing |
phv00195584 |
Gender of participant |
Genetic Modifiers of Huntington's Disease |
phv00173894 |
Gender of participant |
Genetic Variation and Signatures of Natural Selection in Diverse Africans |
phv00171014 |
Gender of participant |
Genetic Variation and Signatures of Natural Selection in Diverse Africans |
phv00171913 |
Gender of participant |
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project) |
phv00071843 |
Gender: male or female |
Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR Project) |
phv00071861 |
Gender: male, female, or null children for pedigree structure |
Genetics of High HDL Cholesterol |
phv00171948 |
Gender of participant |
Genetics of Human Developmental Brain Disorders |
phv00168106 |
Gender of participant |
Genetics of Inherited Muscle Disease |
phv00195631 |
Gender of participant |
Genetics of Inherited Muscle Disease |
phv00220881 |
Gender of participant |
Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics Study |
phv00202103 |
Gender of participant |
Genetics of Neuropsychiatric and Neurodevelopmental Disorders |
phv00196236 |
Gender of participant |
Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort |
phv00165039 |
Gender of participant |
GENEVA Genetics of Early Onset Stroke (GEOS) Study |
phv00111930 |
Participant's gender |
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study |
phv00022834 |
Sex |
Genome Sequencing of Hepatocellular Carcinoma |
phv00218134 |
Gender of participant |
Genome Sequencing of Pancreatic Ductal Adenocarcinoma |
phv00171496 |
Gender of participant |
Genome Variations Among the Aboriginals in Malaysia |
phv00195915 |
Gender of participant |
Genome Wide Association Study in Familial Crohn's Disease |
phv00190278 |
Gender |
Genome Wide Association Study in Familial Crohn's Disease |
phv00190285 |
Gender of participant |
Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study |
phv00165551 |
Gender of participant |
Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS |
phv00090329 |
Gender of participant |
Genome-Wide Analysis of Chronic Lymphocytic Leukemia |
phv00160276 |
Gender of participant |
Genome-Wide Analysis of Hypodiploid ALL |
phv00180571 |
Gender |
Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian) |
phv00159417 |
Gender of participant [FEMALE, MALE] |
Genome-Wide Association Study in Systemic Sclerosis |
phv00161583 |
Subject's gender. |
Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland |
phv00158892 |
Gender of participant |
Genome-Wide Association Study of Anorexia Nervosa |
phv00196926 |
Gender |
Genome-Wide Association Study of Beh+ºet's Disease (Turkish) |
phv00124464 |
Subject gender |
Genome-Wide Association Study of Celiac Disease |
phv00091144 |
Gender of Participant |
Genome-wide Association Study of Myasthenia Gravis |
phv00200998 |
Gender of participant |
Genome-Wide Association Study of Neuroblastoma |
phv00158908 |
Gender of the subject [Female, Male, Unknown] |
Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic Leukemia |
phv00196101 |
Male or female |
Genome-Wide Association Study of Schizophrenia |
phv00020112 |
Sex: male, female |
Genome-Wide Association Study of Schizophrenia |
phv00020235 |
Sex: male, female |
Genome-Wide Association Study of Schizophrenia |
phv00034892 |
Sex: male, female |
Genome-Wide Association Study of Schizophrenia |
phv00034926 |
Sex (male, female) |
Genomic Analysis of Pediatric Low Grade Gliomas |
phv00190510 |
Gender of participant |
Genomic Characterization of Meningiomas |
phv00174205 |
Gender of participant |
Genomic Origins and Admixture in Latinos (GOAL) |
phv00202272 |
Gender of participant |
Genomic Predictors of Combat Stress Vulnerability and Resilience |
phv00222718 |
Gender of participant |
Genomic Sequencing of Cervical Cancers |
phv00182022 |
Gender of participant |
Genomic Sequencing of Colorectal Adenocarcinomas |
phv00162707 |
Participant's gender as Male or Female |
Genomic Sequencing of Pediatric Rhabdoid Cancers |
phv00171414 |
Participant gender as male or female [Male, Female] |
Genomic Sequencing of Pediatric Rhabdomyosarcoma |
phv00201888 |
Patient gender |
Genomic Sequencing of Solitary Fibrous Tumors |
phv00179053 |
Gender of participant |
Genomic Wide Scans for Female Osteoporosis Genes |
phv00161534 |
Sex of study subject. |
Genotype-Tissue Expression (GTEx) |
phv00169062 |
Gender (Demography) |
Genotyping 400 Samples from the NIGMS Human Variation Panels |
phv00076466 |
Gender of participant |
Genotyping NIGMS CEPH Samples from the United States, Venezuela, and France |
phv00158856 |
Gender of participant |
Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples |
phv00110716 |
Gender of participant |
Ghana Prostate Study |
phv00226956 |
Gender of participant |
GWAS for Genetic Determinants of Bone Fragility |
phv00065502 |
Gender of participant |
GWAS in Fibrosing Interstitial Lung Disease |
phv00201842 |
Gender of participant |
GWAS of Breast Cancer in the African Diaspora |
phv00172015 |
Gender of participant |
GWAS of Familial Lung Cancer |
phv00192256 |
Gender of participant |
GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia |
phv00200111 |
Gender of participant [FEMALE, MALE] |
GWAS on Cataract and HDL in the PMRP |
phv00071870 |
Gender of participant |
GWAS on Cataract and HDL in the PMRP |
phv00077312 |
Gender of participant |
Health and Retirement Study (HRS) |
phv00167516 |
Gender of respondent |
HeLa S3 (CCL-2.2) HiC Sequencing |
phv00196373 |
Gender of participant [F] |
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C) |
phv00174312 |
Gender |
High Density SNP Association Analysis of Lung Cancer |
phv00201874 |
Gender of participant [Male, Female] |
High Density SNP Association Analysis of Melanoma |
phv00073646 |
Patient's gender |
HIV-Resistant People with Hemophilia |
phv00165018 |
Gender of participant |
HMP Core Microbiome Sampling Protocol A (HMP-A) |
phv00158769 |
Gender |
HMP Core Microbiome Sampling Protocol A (HMP-A) |
phv00158770 |
Gender - coded fields |
Human Autism Genetics and Activity Dependent Gene Activation |
phv00226789 |
Gender of subject |
Human Gut Microbiome in Amish Obesity |
phv00090513 |
Gender of participant |
Human Gut Microbiome in Crohn's Disease |
phv00090580 |
Subject's gender |
Human Responses to Influenza Vaccination |
phv00217674 |
Sex of participant |
Hypertriglyceridemia Study in Mexicans |
phv00190652 |
Gender of participant |
ICPCG Genome Wide Association Study of Familial Prostate Cancer |
phv00201571 |
Gender of participant |
Identification of Genes Involved in Familial Coronary Artery Disease |
phv00171554 |
Gender of participant |
Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas |
phv00201612 |
Sex of subject |
IgA Nephropathy GWAS (IGANGWAS) |
phv00218099 |
Gender of participant |
IgA Nephropathy GWAS (IGANGWAS) |
phv00164712 |
Gender of participant |
Immunosenescence: Immunity in the Young and Aged |
phv00217650 |
Gender of participant |
Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia |
phv00161465 |
Gender of subject |
Integration of Genomics and Transcriptomics in unselected Twins and in Major Depression |
phv00171371 |
Gender of participant |
International Consortium on the Genetics of Heroin Dependence |
phv00171329 |
Gender |
International Consortium to Identify Genes and Interactions Controlling Oral Clefts |
phv00088044 |
Individual's Gender |
International Multi-Center ADHD Genetics Project |
phv00011566 |
Gender of child |
IPM BioBank GWAS |
phv00162679 |
Gender of subject |
Ischemic Stroke Genetics Study (ISGS) |
phv00024265 |
Gender of the subject |
Ischemic Stroke Genetics Study (ISGS) |
phv00034499 |
Gender of participant (male or female) |
Italian PBC Study |
phv00168044 |
Gender of participant |
Jackson Heart Study (JHS) Cohort |
phv00172142 |
Gender of participant |
Jackson Heart Study (JHS) Cohort |
phv00125546 |
GENDER OF PARTICIPANT (M,F) Q18 |
Jackson Heart Study (JHS) Cohort |
phv00125635 |
GENDER OF PARTICIPANT (M,F) Q18 |
Jackson Heart Study (JHS) Cohort |
phv00125724 |
GENDER OF PARTICIPANT (M,F) Q18 |
Jackson Heart Study (JHS) Cohort |
phv00125811 |
GENDER OF PARTICIPANT (M,F) Q18 |
Jackson Heart Study (JHS) Cohort |
phv00126012 |
Gender of participant |
Jackson Heart Study (JHS) Cohort |
phv00127524 |
4: Participant's gender |
Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset |
phv00202325 |
Gender of participant |
L1-seq and genome-wide SNP genotyping in a multiethnic Asian population |
phv00201446 |
Gender of participant |
Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic Leukemia |
phv00218111 |
Gender of participant |
Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration |
phv00020553 |
Gender, Tier1 |
Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) Collaboration |
phv00024092 |
Gender, Tier2 |
Medulloblastoma exome sequence analysis |
phv00171448 |
Participant's gender as Male or Female |
Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes |
phv00225801 |
Gender of participant |
Melanoma Exome Sequencing |
phv00226764 |
Gender of participant |
Melanoma Genome Sequencing Project |
phv00167383 |
Gender of patient [Male, Female] |
Metabolism and Genetics of Hypobetalipoproteinemia |
phv00174227 |
Gender of participant |
Metagenomic Study of the Human Skin Microbiome Associated with Acne |
phv00090394 |
Gender of participant |
Methotrexate Clearance GWAS |
phv00195886 |
Male or female |
Minnesota Center for Twin and Family Research (MCTFR) |
phv00201962 |
Gender of participant |
miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients |
phv00201810 |
Gender of participant |
MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH) |
phv00156596 |
Gender of participant |
Molecular Defects in Pseudohypoparathyroidism or Related Disorders |
phv00167913 |
Gender of participant |
Molecular Genetic Analysis of Inherited Kidney Dysfunction |
phv00167971 |
Gender of participant |
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN) |
phv00071338 |
Gender: male or female |
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN) |
phv00071461 |
Gender where 1 = male, 2 = female |
Molecular Profiling of Cancer |
phv00165136 |
Gender of participant |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00082643 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00084446 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00085782 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00086268 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00086736 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00087073 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00174586 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00175856 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00175877 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00175940 |
FAMILY COHORT: GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00176009 |
GENDER |
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort |
phv00219022 |
GENDER |
Multiethnic Cohort (MEC) Breast Cancer Genetics |
phv00173161 |
Gender |
N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES) |
phv00222601 |
Gender of participant |
NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing |
phv00174514 |
Gender |
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (HTMCP - DLBCL) |
phv00173789 |
Gender |
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer (HTMCP - LC) |
phv00190993 |
Gender |
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Medulloblastoma |
phv00173796 |
Gender |
National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): Non-Hodgkin Lymphoma |
phv00173803 |
Gender |
NCI Genome-Wide Association Study of Renal Cell Carcinoma |
phv00159249 |
Gender of participant |
NCI GWAS of Lung Cancer in Never Smokers |
phv00201633 |
Gender of participant |
NCI GWAS of Renal Cell Carcinoma in African Americans |
phv00226593 |
Gender of participant [MALE, FEMALE] |
NCI Non-Hodgkin Lymphoma GWAS |
phv00225218 |
Gender of participant |
NCI Non-Hodgkin Lymphoma GWAS |
phv00225228 |
Gender of participant |
NEI Ocular Hypertension Treatment Study (OHTS) |
phv00160401 |
Gender of participant |
NEIGHBOR Consortium Glaucoma GWAS |
phv00129642 |
Gender 1: Male, 2: Female, 999: Missing |
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes |
phv00194003 |
Gender of participant as identified by survey of patient/patient's parent |
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes |
phv00194909 |
Subject's gender |
Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS) |
phv00197289 |
Gender |
Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS) |
phv00197294 |
Gender |
Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII |
phv00174271 |
Subject's gender |
Next Generation Mendelian Genetics: Familial Hemophagocytic Lymphohistiocytosis |
phv00174188 |
Gender of participant |
Next Generation Mendelian Genetics: Hereditary Neurological Disorders |
phv00200320 |
Gender |
NGS in Advanced Cancers |
phv00195642 |
Gender of participant |
NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE) |
phv00121845 |
Gender |
NHGRI Tumor Sequencing Project (Lung Adenocarcinoma) |
phv00071771 |
Gender of participant |
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe) |
phv00122007 |
Subject's gender |
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe) |
phv00122989 |
Subject's Gender |
NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension |
phv00191044 |
Gender |
NHLBI GO-ESP: Family Studies (Aortic Disease) |
phv00179491 |
Gender of participant |
NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis) |
phv00179565 |
Gender of participant |
NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy) |
phv00181166 |
Gender of participant |
NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia) |
phv00182046 |
Gender of participant |
NHLBI GO-ESP: Family Studies (Hematological Cancers) |
phv00196142 |
Gender of participant |
NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders) |
phv00195790 |
Gender of participant |
NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation) |
phv00181914 |
Gender of participant |
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC) |
phv00190418 |
Values: Male; Female |
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS) |
phv00179584 |
Values: Male; Female |
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS) |
phv00174111 |
GENDER OF PARTICIPANT |
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma) |
phv00181856 |
Gender of participant |
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis) |
phv00159434 |
Gender of participant. |
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis) |
phv00159440 |
Gender of participant. |
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP |
phv00161367 |
GENDER OF PARTICIPANT |
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci |
phv00071268 |
Gender: male or female |
NIA - Late Onset Alzheimer's Disease and National Cell Repository for Alzheimer's Disease Family Study: Genome-Wide Association Study for Susceptibility Loci |
phv00071321 |
Gender: male, female, or null (children for pedigree structure) |
NIA Long Life Family Study (LLFS) |
phv00163237 |
Gender |
NIDCR Sjogren's International Collaborative Clinical Alliance (SICCA) |
phv00226846 |
Gender of participant |
NIDDK Drug-Induced Liver Injury Network (DILIN) |
phv00195956 |
Gender |
NIDDK Gene discovery in FSGS |
phv00202568 |
Gender of participant |
NIDDK Gene discovery in VUR |
phv00202545 |
Gender of participant |
NIDDK Genetics of Metabolic Syndrome in an Island Population |
phv00222296 |
Sex |
NIDDK Genetics of Metabolic Syndrome in an Island Population |
phv00222305 |
Sex |
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00200477 |
Gender of participant |
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00088181 |
Gender of participant |
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00158872 |
Gender of participant |
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00024103 |
Subject's gender |
NIH Exome Sequencing of Familial Amyotrophic Lateral Sclerosis Project |
phv00024162 |
Subject's gender |
NINDS Parkinson's Disease |
phv00023939 |
Gender of the subject |
NINDS Parkinson's Disease |
phv00024005 |
Gender of the subject |
NINDS Parkinsonism Study |
phv00000187 |
Gender of the subject |
NINDS Repository Cerebrovascular Disease/Stroke Study |
phv00024079 |
Gender of the subject |
NINDS Repository Motor Neuron Disease/ALS Study |
phv00020520 |
Gender of the subject |
NINDS Repository Neurologically Normal Control Collection |
phv00000225 |
Gender of the subject |
NINDS Stroke Genetics Network (SiGN) |
phv00190672 |
Self reported gender |
Northwestern NUgene Project: Type 2 Diabetes |
phv00158808 |
Gender of participant |
Northwestern NUgene Project: Type 2 Diabetes |
phv00158818 |
Gender |
OMRF SLEGEN GWAS Data from European-American Women with Lupus |
phv00076097 |
Gender of subject |
Oncogenomics of Malignant Peripheral Nerve Sheath Tumors |
phv00217577 |
Gender of participant |
Osteosarcoma Genome-wide Association Study |
phv00200964 |
Gender of participant [FEMALE, MALE] |
Osteosarcoma Genomics |
phv00220907 |
Gender of patient |
PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project |
phv00196394 |
Gender of participant |
PAGE: Multiethnic Cohort (MEC) |
phv00163089 |
Gender |
Paired AML Epigenetics Study on Clonality |
phv00202812 |
Gender of participant |
Pancreatic Cancer Case-Control Association Study |
phv00226238 |
Gender |
Pancreatic Cancer Cohort and Case-Control Consortium (PanScan) |
phv00076258 |
Gender of the participant |
Pediatric Cardiac Genetics Consortium (PCGC) |
phv00191088 |
Subject's gender |
PGC: the PUWMa GWAS of ADHD |
phv00159878 |
Gender of participant |
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS) |
phv00195982 |
Gender |
PGRN-RIKEN: Identification of Genetic Predictors of ACE Inhibitor-Associated Angioedema |
phv00190844 |
Gender |
PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation |
phv00173383 |
Gender of participant |
Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study |
phv00173925 |
Gender of participant |
Pilocytic Astrocytoma in NF1 |
phv00174531 |
Gender of participant |
POLYGEN |
phv00160468 |
Gender of participant |
POLYGEN |
phv00160479 |
Gender of participant |
POPRES: Population Reference Sample |
phv00066614 |
Gender used by POPRES. Reported if exists, else inferred from sex linked data if successfully genotyped. |
PREDICT-HD Huntington Disease Study |
phv00172057 |
Gender |
Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole |
phv00222697 |
Gender of participant |
Prostate Cancer Genome Sequencing Project |
phv00167303 |
Gender of participant [Male, Female] |
RAD50 Hypomorphism as Basis for Response to Chemotherapy |
phv00197161 |
Gender |
Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU |
phv00174357 |
Gender of participant |
Rare Mendelian Disease in Old Order Amish and Mennonite Patients |
phv00190988 |
Participant's gender as Male or Female |
Resistance studies in Lung Cancer |
phv00224917 |
Gender of participant |
Resource for Genetic Epidemiology Research on Aging (GERA) |
phv00196838 |
Gender |
Responses to Varicella Zoster Virus Vaccination |
phv00221173 |
Sex |
Responses to Varicella Zoster Virus Vaccination |
phv00221179 |
Gender of participant |
Retrotransposition in Colorectal Cancer |
phv00173541 |
Gender of participant |
Risk Assessment of Cerebrovascular Events (RACE) Study |
phv00167701 |
Subject's gender |
RM Epigenomics Program - Broad_Alz_and_Age-Related |
phv00191101 |
Gender of participant |
RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in Autism |
phv00190495 |
Gender of participant |
RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease |
phv00201726 |
Gender of participant |
San Francisco Bay Area Latina Breast Cancer Study |
phv00226550 |
Gender of participant |
SardiNIA Medical Sequencing Discovery Project |
phv00141809 |
Gender of individual |
SardiNIA Medical Sequencing Discovery Project |
phv00141813 |
Gender of individual |
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK |
phv00020794 |
Participant's gender - See also GAIN - GoKinD phs000018: SEX |
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN |
phv00019965 |
Participant's gender - See also NIDDK - GoKinD phs000088: SEX |
Sensitivity to the subjective effects of amphetamine |
phv00221225 |
Gender of participant |
Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes |
phv00167357 |
Participant's gender as male or female [Male, Female] |
Sequencing of ETP T-ALL |
phv00159267 |
Gender |
Sequencing of Medulloblastoma |
phv00169041 |
Gender |
Sequencing of Retinoblastoma |
phv00160438 |
Gender |
Sequencing of Targeted Genomic Regions Associated with Smoking |
phv00217965 |
Participant gender |
Shanghai Breast Cancer Genetics Study (SBCGS) |
phv00217898 |
Gender of participant [female, male] |
Single Cell Analysis Program - Transcriptome (SCAP-T) |
phv00219205 |
Gender of the subject |
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency |
phv00090676 |
Gender of participant |
Small Intestine Neuroendocrine Tumors (Carcinoid Tumors) |
phv00190468 |
Participant's gender as Male or Female |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00070936 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00070997 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071047 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071105 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071155 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071213 |
Gender of participant |
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP) |
phv00071823 |
Gender |
Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia |
phv00195931 |
Gender of participant |
Spatiotemporal Transcriptome of the Human Brain |
phv00163221 |
Gender of subjects |
Spectrum of Mutations in Myeloid Neoplasms |
phv00202080 |
Gender of participant |
Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study |
phv00252380 |
Biological gender of subject |
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966) |
phv00129605 |
Gender of participant |
Strabismus, CCDD and Other Anomalies |
phv00167779 |
Gender of participant |
Strong Activation of Retroviral LTRs in HCC |
phv00225166 |
Gender of participant |
Study of Adaptation to Hypoxia in Ethiopian Highlanders |
phv00195533 |
Gender of participant |
Study of Addiction: Genetics and Environment (SAGE) |
phv00022888 |
Participant's gender |
Study of Irish Amyotrophic Lateral Sclerosis (SIALS) |
phv00066544 |
Participant's gender |
Study of Irish Amyotrophic Lateral Sclerosis (SIALS) |
phv00066550 |
Participant's gender |
Study of Melanoma Risk in Australia and the United Kingdom |
phv00182063 |
Gender |
Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing |
phv00167461 |
Gender of participant |
TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2 |
phv00167582 |
Gender |
TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1 |
phv00167559 |
Gender |
TARGET: Acute Myeloid Leukemia (AML) |
phv00167605 |
Gender |
TARGET: Cancer Model Systems (MDLS): Cell Lines and Xenografts (including PPTP) |
phv00167654 |
Gender |
TARGET: Kidney, Clear Cell Sarcoma of the Kidney (CCSK) |
phv00167612 |
Gender |
TARGET: Kidney, Rhabdoid Tumor (RT) |
phv00167661 |
Gender |
TARGET: Kidney, Wilms Tumor (WT) |
phv00167668 |
Gender |
TARGET: Neuroblastoma (NBL) |
phv00167620 |
Gender |
TARGET: Osteosarcoma (OS) |
phv00167647 |
Gender |
Targeted Sequencing of GWAS Loci in Cleft Lip and Palate |
phv00201753 |
Gender of participant |
Temporal Dissection of Tumorigenesis in Primary Cancers |
phv00167535 |
Gender |
The Collaborative Study on the Genetics of Alcoholism (COGA) |
phv00217592 |
Gender Status |
The Collaborative Study on the Genetics of Alcoholism (COGA) |
phv00217635 |
Gender Status |
The Detroit Neighborhood Health Study (DNHS) |
phv00174401 |
Gender of participant. |
The Familial Intracranial Aneurysm Linkage Study (FIA) |
phv00191116 |
Gender |
The Familial Intracranial Aneurysm Linkage Study (FIA) |
phv00191121 |
Gender |
The Finland-United States Investigation of NIDDM Genetics (FUSION) - GWAS Study |
phv00087897 |
Gender of participant |
The Gene Partnership (TGP) - eMERGE Data |
phv00171962 |
Gender of Subject - as reported by participant |
The Gene Partnership (TGP) - eMERGE Data |
phv00172003 |
Gender of sample - as indicated by genotype analysis |
The Genetic Architecture of Smoking and Smoking Cessation |
phv00162801 |
Participant's gender |
The Genetic Architecture of Smoking and Smoking Cessation |
phv00162918 |
Participant's gender |
The Genetic Landscape of Mutations in Burkitt Lymphoma |
phv00178124 |
Gender of participant |
The Genomic Complexity of Primary Human Prostate Cancer |
phv00154533 |
Gender of participant |
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial |
phv00159330 |
Gender (male, female) |
The Glaucoma Genes and Environment (GLAUGEN) Study |
phv00142513 |
NHS/HPFS/GEP: Gender |
The Human Gut Microbiome and Recurrent Abdominal Pain in Children |
phv00091112 |
Gender of participant |
The Human Virome and Febrile Illness in Children |
phv00098405 |
Gender of participant |
The Molecular Basis of Inherited Reproductive Disorders |
phv00167992 |
Gender of participant |
The mutational characterization of adenoid cystic carcinoma |
phv00195824 |
Gender of the participate |
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma |
phv00163064 |
Participant's gender [Male, Female] |
The Neonatal Microbiome and NEC |
phv00091251 |
Sex of subject |
The Neonatal Microbiome and NEC |
phv00091258 |
Sex of subject |
The Role of the Gut Microbiota in Ulcerative Colitis |
phv00091161 |
Gender |
The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study |
phv00202243 |
Gender of participant |
Towards a Genomic Understanding of Myeloma |
phv00159451 |
Participant's gender as Male or Female |
Transcriptome Sequencing of Pediatric AML FAB-M7 |
phv00174237 |
Gender |
Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V - HTG Amsterdam |
phv00171438 |
Gender of participant |
Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV) Study |
phv00226507 |
Gender of participant |
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing |
phv00066340 |
Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female |
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing |
phv00066354 |
Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female |
Type 2 Diabetes Starr County GWAS and Exome Sequencing |
phv00066507 |
Gender |
Tyrosine Kinase Mutations in Endometrial Cancer |
phv00221198 |
Gender of participant |
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders) |
phv00171540 |
Gender of participant |
University of Michigan Clinical Sequencing Exploratory Research (CSER) |
phv00197132 |
Gender of participant |
University of Washington Center for Mendelian Genomics (UW-CMG) |
phv00197223 |
Subject's sex |
University of Washington Center for Mendelian Genomics (UW-CMG) |
phv00197228 |
Subject's sex |
University of Washington CSF biomarker study for Parkinson disease |
phv00225944 |
Gender of participant |
Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration |
phv00077277 |
Gender of participant |
VESPA: Genome Wide Study of Vancomycin |
phv00225885 |
Gender of participant |
VitGene Generalized Vitiligo Genetics Study |
phv00158991 |
Gender of participant |
Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex Families |
phv00163339 |
Gender of participant |
Whole Exome and Transcriptome Sequencing in Sporadic ALS |
phv00201705 |
Gender of participant |
Whole Exome Sequence of Hearing Loss Family |
phv00252647 |
Gender of participant |
Whole Exome Sequencing for Colorectal Cancer |
phv00163736 |
Gender of participant |
Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study |
phv00193922 |
Gender |
Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II) Study |
phv00193929 |
Gender |
Whole Exome Sequencing of Chronic Lymphocytic Leukemia |
phv00165095 |
Participant's gender as Male or Female. |
Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma |
phv00165116 |
Participant's gender [Male or Female] |
Whole Genome Association Study of Bipolar Disorder |
phv00011576 |
A1. Sex. (Participants with European ancestry). DIGS2 |
Whole Genome Association Study of Bipolar Disorder |
phv00016991 |
A1. Gender. INTERVIEWER: circle sex code. (Participants with European ancestry). DIGS4 |
Whole Genome Association Study of Bipolar Disorder |
phv00035052 |
Sex: male, female. (Participants with European ancestry) |
Whole Genome Association Study of Bipolar Disorder |
phv00035338 |
Sex: male or female, (Participants with European ancestry). DIGS3 |
Whole Genome Association Study of Bipolar Disorder |
phv00051908 |
A1 Gender, (African American participants). DIGS4 |
Whole Genome Association Study of Bipolar Disorder |
phv00054360 |
Sex: male, female. (African American participants) |
Whole Genome Association Study of Systemic Lupus Erythematosus |
phv00066360 |
Gender |
Whole Genome Association Study of Visceral Adiposity in the HABC Study |
phv00071826 |
Gender |
Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors |
phv00066468 |
Gender of participant |
Whole Genome Comparisons of Breast Cancers and their Xenotransplants |
phv00195712 |
Subject's gender |
Whole Genome Profiling to Detect Schizophrenia Methylation Markers |
phv00191011 |
Gender status |
Whole Genome Sequencing of Triple Negative Breast Cancer |
phv00124471 |
Gender of participant |
Whole Genome Sequencing of Two 22q11DS Trios |
phv00222265 |
Gender of participant |
Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma |
phv00168012 |
Gender of participant |
Whole-genome sequencing in multiplex epilepsy families |
phv00196481 |
Self-declared gender of participant |
Whole-Genome Sequencing of Acute Myeloid Leukemia |
phv00073670 |
Gender of participant |
XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study |
phv00252611 |
Gender of participant |
Yale Center for Mendelian Genomics (Y CMG) |
phv00202582 |
Subject's gender |
Yale Center for Mendelian Genomics (Y CMG) |
phv00202587 |
Subject's gender |